Research Centers of Excellence
Dr. Gabriel G. Malouf MD, PhD provides a good overview of rare kidney cancers at the molecular level for patients and physicians.
Presented at the 2016 GUASCO conference in San Francisco
Due to their small population, few resources and fewer clinical trials are devoted exclusively to patients with rare kidney cancer (also call "non clear cell renal cell carcinoma" or nccRcc).
Research update from a 2018 Hackathon Team: Marvin Weinstein and Bernard Chen of Quantum Insights (Original Document Here). I go into more detail on the implications of this in a a recent blog post).
I recently had a discussion about the value of hackathons.
Here was my argument.
The Problem: Cancer Research Doesn't Work
Invited talk at Clemson (Thanks Alex Feltus).
No partners have been featured.
Copyright © 2016